What the FDA labels say about taking them together
Ramipril and simvastatin
Neither FDA label names the other in its interaction, contraindication or warning sections. A label lists the interactions its studies and reports found; it is not a complete list, so ask a pharmacist before combining medicines. Labels read October 8, 2026.
Check it at the source: the ramipril FDA label on DailyMed (effective August 24, 2026, Lupin Pharmaceuticals, Inc.); the simvastatin FDA label on DailyMed (effective March 28, 2025, Organon LLC).
What does the ramipril label say about simvastatin?
Ramipril's label (effective August 24, 2026) does not name simvastatin in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (Ramipril), Lupin Pharmaceuticals, Inc., effective August 24, 2026 (SPL set a8cdec12-81d1-4ef4-82c0-d05d93c37a07), via openFDA; the full label on DailyMed
What does the simvastatin label say about ramipril?
Simvastatin's label (effective March 28, 2025) does not name ramipril in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (ZOCOR), Organon LLC, effective March 28, 2025 (SPL set 8f55d5de-5a4f-4a39-8c84-c53976dd6af9), via openFDA; the full label on DailyMed
A pharmacist or prescriber can say whether these two medicines suit one person together; PlainMeds does not grade interactions.
Both medicines on the record
| Ramipril | Simvastatin | |
|---|---|---|
| Labeled for | High blood pressure, Heart attack and coronary artery disease | Heart attack and coronary artery disease, High cholesterol, High triglycerides |
| Boxed warning | Yes | No |
| Pharmacy cost (NADAC) | $0.0707 per capsule 10 mg capsule | $0.0321 per tablet 20 mg tablet |
| Shortage now | No current entry | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once